Co-electrodeposited hydrogel-conducting polymer electrodes for biomedical applications
US-2015369771-A1 · Dec 24, 2015 · US
US9679672B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9679672-B2 |
| Application number | US-201314394198-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 12, 2013 |
| Priority date | Apr 13, 2012 |
| Publication date | Jun 13, 2017 |
| Grant date | Jun 13, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In one aspect, electrically conductive conjugated polymeric compositions are described herein demonstrating compatibility with aqueous solvents and/or phases. The ability to provide aqueous compatible compositions from previously water insoluble conjugated polymeric systems, in some embodiments, can facilitate use of such systems in a variety of aqueous applications, including biological applications.
Opening claim text (preview).
That which is claimed is: 1. A composition comprising: an aqueous medium; and particles of at least one water insoluble conjugated copolymer dispersed in the aqueous medium, the particles having a band gap ranging from about 1.1 eV to about 1.8 eV, wherein the water insoluble conjugated copolymer has a donor-acceptor architecture comprising a donor monomeric species (D) and an acceptor monomeric species (A), wherein the donor monomeric species is a fused dithiophene of the formula wherein the acceptor monomeric species is a benzodiazole of the formula wherein R 1 and R 2 are selected from the group consisting of hydrogen, alkyl, alkenyl, aryl, heteroaryl, O-alkyl, O-alkenyl, and O-aryl, and wherein X is selected from the group consisting of oxygen, nitrogen, sulfur and selenium. 2. The composition of claim 1 , wherein the particles of the water insoluble conjugated copolymer are nanotubes or other anisotropically shaped nanoparticles. 3. The composition of claim 2 , wherein the nanotubes or other anisotropically shaped nanoparticles have a length ranging from 1 nm to 10 μm. 4. The composition of claim 2 , wherein the nanotubes or other anisotropically shaped nanoparticles have a length ranging from 200 nm to 600 nm. 5. The composition of claim 2 , wherein the nanotubes or other anisotropically shaped nanoparticles have a diameter ranging from 1 nm to 500 nm. 6. The composition of claim 2 , wherein the nanotubes or other anisotropically shaped nanoparticles have a diameter ranging from 15 nm to 300 nm. 7. The composition of claim 1 , wherein the particles of the water insoluble conjugated copolymer are dispersed in the aqueous medium to provide a colloid. 8. The composition of claim 7 , wherein the particles of the water insoluble conjugated copolymer are at least partially encapsulated by a dispersing agent. 9. The composition of claim 8 , wherein the dispersing agent comprises a surfactant. 10. The composition of claim 9 , wherein the surfactant is a non-ionic polyol. 11. The composition of claim 8 , wherein the dispersing agent is a phospholipid. 12. The composition of claim 1 , wherein the particles are conjugated or attached to one or more targeting agents, the targeting agents comprising an antibody, a chemokine receptor, and/or a targeting ligand. 13. The composition of claim 1 , wherein the water insoluble conjugated copolymer is present in the aqueous medium at a concentration of 1 ng/ml to 100 mg/ml. 14. The composition of claim 1 , wherein the water insoluble conjugated copolymer is present in the aqueous medium at a concentration of 1 μg/m 1 to 120 μg/ml. 15. The composition of claim 1 , wherein the water insoluble conjugated copolymer is present in the aqueous medium at a concentration of 5 μg/ml to 30μg/ml. 16. The composition of claim 1 , wherein the water insoluble conjugated copolymer is present in the aqueous medium at a concentration of 15 μg/ml to 25 μg/ml. 17. The composition of claim 1 , wherein X is selenium. 18. The composition of claim 1 , wherein X is nitrogen. 19. The composition of claim 1 , wherein particles of the at least one water insoluble conjugated copolymer are not dispersed by surfactant.
Antibacterial agents · CPC title
Antineoplastic agents · CPC title
infrared · CPC title
containing nitrogen and sulfur as heteroatoms · CPC title
containing combinations of different heteroatoms other than nitrogen and oxygen or nitrogen and sulfur · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.